Clinical Trial Update: Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of gemcitabine and capecitabine in patients with advanced pancreatic cancer and biliary tract cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Pancreatic Cancer, Biliary Cancer | Phase 1 | Status: COMPLETED